Jaguar Health Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 30.23, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Jaguar Health Inc in Jun 30 2026 quarter, has decreased to 12 days, compared to 15 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 36 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 501, from overall ranking in the first quarter 2026 at 1421.

What is Receivable Turnover Ratio?
What is Jaguar Health Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

JAGX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-84.95 %	-79.84 %	3.1 %	15.16 %	-3.52 %
Y / Y Revenue Change	-58.88 %	815.63 %	-7.81 %	-0.8 %	9.48 %
Receivable Turnover Ratio (TTM)	30.23	24.65	7.79	8.05	8.35
JAGX's Total Ranking	# 501	# 1421	# 1428	# 1526	# 2449
Accounts Receivable average collection period days	12	15	47	45	44
Seq. Receivable Change	-29.29 %	-83.51 %	12.9 %	14.29 %	-5.26 %
Seq. Revenue Change	-93.96 %	526.65 %	4.93 %	3.49 %	34.55 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 14
Healthcare Sector	# 37
Overall Market	# 501

Receivable Turnover Ratio Statistics
High	Average	Low
325.21	18.17	1.25
(Jun 30 2017)		(Dec 31 2021)

JAGX Company Profile • Back to JAGX Efficiency Comparisons • Compare JAGX Receivables Turnover Ratio to its Competitors

Financial Statements
Jaguar Health Inc 's Accounts Receivable	$ 0 Millions	Visit JAGX's Balance sheet
Jaguar Health Inc 's Sales TTM	$ 28 Millions	Visit JAGX's Income Statement
Sources of JAGX's Revenues		Visit JAGX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
JAGX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
JAGX's Growth Rates	JAGX's Roa	JAGX's Inventory Turnover Ratio	JAGX's Dividend Comparisons
JAGX's Profitability Ratios	JAGX's Roi	JAGX's Asset Turnover Ratio	JAGX's Dividend Growth
JAGX's Valuation Ratios	JAGX's Roe	JAGX's Financial Strength Ratios	JAGX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Nakamoto Inc	386.16	$ 28.962 Millions	$ 0.075 Millions
Agape Atp Corporation	191.14	$ 1.152 Millions	$ 0.006 Millions
Hcw Biologics Inc	175.24	$ 6.843 Millions	$ 0.039 Millions
Meiragtx Holdings Plc	108.27	$ 397.501 Millions	$ 3.671 Millions
Sbc Medical Group Holdings Incorporated	97.18	$ 173.713 Millions	$ 1.787 Millions
Assembly Biosciences Inc	94.77	$ 74.845 Millions	$ 0.790 Millions
Earth Science Tech Inc	88.94	$ 34.647 Millions	$ 0.390 Millions
Lenz Therapeutics Inc	77.11	$ 21.475 Millions	$ 0.279 Millions
Lifevantage Corp	65.04	$ 180.947 Millions	$ 2.782 Millions
Stablecoin Development Corporation	61.16	$ 5.627 Millions	$ 0.092 Millions
Arrowhead Pharmaceuticals Inc	60.05	$ 669.495 Millions	$ 11.149 Millions
Vireo Growth Inc.	58.33	$ 511.706 Millions	$ 8.773 Millions
Fortrea Holdings Inc	56.65	$ 2,676.500 Millions	$ 47.250 Millions
Caribou Biosciences Inc	54.17	$ 10.035 Millions	$ 0.185 Millions
Humacyte Inc	52.69	$ 30.074 Millions	$ 0.571 Millions
Brookdale Senior Living Inc	47.66	$ 3,050.697 Millions	$ 64.009 Millions
National Vision Holdings Inc	44.61	$ 2,033.426 Millions	$ 45.586 Millions
Metagenomi Therapeutics Inc	42.88	$ 13.561 Millions	$ 0.316 Millions
Nature s Sunshine Products inc	39.24	$ 491.790 Millions	$ 12.532 Millions
Jaguar Health Inc	36.67	$ 27.815 Millions	$ 0.759 Millions
Electrocore Inc	34.09	$ 36.527 Millions	$ 1.072 Millions
Innovative Eyewear Inc	31.49	$ 3.412 Millions	$ 0.108 Millions
Cv Sciences Inc	31.22	$ 12.066 Millions	$ 0.387 Millions
Ginkgo Bioworks Holdings Inc	30.60	$ 111.863 Millions	$ 3.656 Millions
Innovage Holding Corp	30.33	$ 989.707 Millions	$ 32.630 Millions
Invo Fertility Inc	30.20	$ 7.531 Millions	$ 0.249 Millions
Kiniksa Pharmaceuticals International Plc	29.49	$ 840.848 Millions	$ 28.513 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.